Skip to content

Posts by Former NIMH Director Thomas Insel about Clinical Research and Trials

New hope for treating psychosis

By Thomas Insel on

Results from a major NIMH project provide evidence that coordinated specialty care can improve outcomes for first episode psychosis. Dr. Insel blogs about the RAISE project and other recent studies of coordinated care.

Read More

Look who is getting into mental health research

By Thomas Insel on

Tech companies are bringing their ability to extract knowledge from data to health care. Dr. Insel gives some examples that show the potential of new tech-based approaches to diagnosis and treatment.

Read More

August at NIMH

By Thomas Insel on

Despite its reputation as a month for slowing down, August is busy at NIMH as the end of the fiscal year approaches. Dr. Insel takes time out to give an update on NIMH-supported clinical trials.

Read More

Something Interesting is Happening

By Thomas Insel on

Dr. Insel discusses how the Precision Medicine Initiative will create a new kind of patient-driven research, which is similar to how innovative companies have created a new share economy based on trust.

Read More

Lost in Translation

By Thomas Insel on

Drug testing in mice has been a poor guide to effectiveness in humans; Dr. Insel talks about the need for research approaches that can more reliably guide medication development.

Read More

From My Data to Mined Data

By Thomas Insel on

Dr. Insel discusses the importance of data sharing within the scientific community and highlights how NIMH is encouraging this process.

Read More

Clues to Risk and Resilience: Army STARRS

By Thomas Insel on

Dr. Insel talks about just published findings coming out of Army STARRS, a joint Army-NIMH effort to understand risk factors for suicide in the military.

Read More

A New Approach to Clinical Trials

By Thomas Insel on

NIMH is changing how it will support clinical trials. Dr. Insel summarizes the changes and the reasons behind them.

Read More

Network Solutions

By Thomas Insel on

Dr. Insel talks about how NIMH’s RAISE study is exploring an integrated, multi-component approach to health care for schizophrenia.

Read More

From Practice to Research

By Thomas Insel on

Dr. Insel introduces an innovative approach that one group is taking to speed up the dissemination of research results into clinical practice.

Read More

A Promising Behavioral Treatment for Tourette Syndrome

By Thomas Insel on

Dr. Insel describes a new behavioral treatment for a neurologically based disorder that has traditionally been difficult to treat. 

Read More

Experimental Medicine

By Thomas Insel on

Dr. Insel discusses the crisis of medication development for mental disorders.

Read More

Citizen Science

By Thomas Insel on

Presentations at a recent meeting in San Diego showed how new technologies are being used to change the culture of science, empowering patients, and fueling innovative research approaches.

Read More

The Future of Psychiatry (= Clinical Neuroscience)

By Thomas Insel on

While fewer medical students are choosing psychiatry in the U.K., in the U.S. psychiatry is attracting increasing numbers of elite MD-PhD students who want to do research. These young scientists are committed to developing a new scientific basis for clinical care.

Read More

Treatment Development: Where do we go from here?

By Thomas Insel on

Dr. Insel discusses opportunities for treatment development.

Read More

NIMH’s Top 10 Research Advances of 2011

By Thomas Insel on

Dr. Insel shares NIMH’s Top 10 Research Advances for 2011.

Read More

Treatment Development: Where do we go from here?

By Thomas Insel on

Dr. Insel discusses opportunities for treatment development.

Read More

Treatment Development: The Past 50 Years

By Thomas Insel on

Dr. Insel discusses the state of psychiatric research and development (R&D) in the public and private sectors

Read More

Antidepressants: A complicated picture

By Thomas Insel on

Dr. Insel discusses the complicated nature of research on the efficacy antidepressants.

Read More

Neuroscience Advances Showcased in Washington

By Thomas Insel on

Dr. Insel reflects on an exciting neuroscience conference where an increasing interest in neuropsychiatric disorders was evident.

Read More

Making the Most of our Interventions Research

By Thomas Insel on

Dr. Insel provides a vision for future clinical research.

Read More

Taking Clinical Research to the Next Level

By Thomas Insel on

Dr. Insel discusses the evolution of clinical research and changing priorities in clinical research funding.

Read More

Microbes and Mental Illness

By Thomas Insel on

Increasing evidence linking strep infection to OCD in children suggests that microbiomics may prove an important research area for understanding and treating mental disorders.

Read More

Three Principles for Clinical Research

By Thomas Insel on

Dr. insel discusses two important initiatives that will have a broad impact on NIMH’s clinical research portfolio.

Read More